Addressing the issue of cost of treatment in CLL
Panel discussion on novel therapies and targets for lymphoma
John Gribben et al.
Lymphoma: chemotherapy vs. bendamustine
Mathias J Rummel
Multiple myeloma highlights from ASCO 2016: monoclonal antibodies and oral proteasome inhibitors
What is the best treatment in the next few years to achieve more treatment-free remission in CML?